Do patients with recurrent episodes of campylobacteriosis differ from those with a single disease event?

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Arsenault, Julie ^a   Ravel, André ^a,b   Michel, Pascal ^a,b   Berke, Olaf ^c   Gosselin, Pierre ^a,d,e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTERIOSIS; CHILD; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PRESCHOOL CHILD; RECURRENT DISEASE; RISK FACTOR; SEX RATIO; STATISTICAL MODEL; SURVIVAL;

ADOLESCENT; ADULT; AGED; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RECURRENCE; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 78651263485     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-32     Document Type: Article

References (41)

1. Notifiable Diseases On-Line. http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ ndis/index-e.html
2. Estimated numbers of community cases of illness due to Salmonella, Campylobacter and verotoxigenic Escherichia coli: Pathogen-specific community rates. MK Thomas SE Majowicz PN Sockett A Fazil F Pollari K Doré JA Flint VL Edge, Can J Infect Dis Med Microbiol 2006 17 229 234 18382633
3. A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. IA Gillespie SJ O'Brien JA Frost GK Adak P Horby AV Swan MJ Painter KR Neal, Emerg Infect Dis 2002 8 937 942 12194770
4. Spatial analysis of Campylobacter infection in the Canadian province of Manitoba. CG Green D Krause J Wylie, Int J Health Geogr 2006 5 2 10.1186/1476-072X-5-2 16412246
5. Immunity to Campylobacter: its role in risk assessment and epidemiology. AH Havelaar W van Pelt CW Ang JA Wagenaar JP van Putten U Gross DG Newell, Crit Rev Microbiol 2009 35 1 22 10.1080/10408410802636017 19514906
6. Host-pathogen interactions in Campylobacter infections: the host perspective. R Janssen KA Krogfelt SA Cawthraw W van Pelt JA Wagenaar RJ Owen, Clin Microbiol Rev 2008 21 505 518 10.1128/CMR.00055-07 18625685
7. Duration of excretion period of Campylobacter jejuni in human subjects. EP Wright, Campylobacter: Epidemiology, pathogenesis and Biochemistry Lancaster, England: MTP Press Limited, Newell DG, 1981 294 298
8. Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children. MR Rao AB Naficy SJ Savarino R Abu-Elyazeed TF Wierzba LF Peruski I Abdel-Messih R Frenck JD Clemens, Am J Epidemiol 2001 154 166 173 10.1093/aje/154.2.166 11447051
9. Ministère de la Santé et des Services sociaux du Québec, Surveillance des maladies déclaration obligatoire au Québec Québec: Direction de la santé publique, Bureau de surveillance et de vigie sanitaire 2002
10. Age related susceptibility to Campylobacter jejuni infection in a high prevalence population. NJ Richardson HJ Koornhof VD Bokkenheuser Z Mayet EU Rosen, Arch Dis Child 1983 58 616 619 10.1136/adc.58.8.616 6614976
11. Human campylobacteriosis in developing countries. AO Coker RD Isokpehi BN Thomas KO Amisu CL Obi, Emerg Infect Dis 2002 8 237 244 10.3201/eid0803.010233 11927019
12. Campylobacter infections in developing countries. RA Oberhelman DN Taylor, Campylobacter Washington, D.C.: ASM Press, Nachamkin I, Blaser MJ, 2 2000 139 153
13. Diffusion of thermophilic Campylobacter in the Pesaro-Urbino area (Italy) from 1985 to 1992. W Baffone F Bruscolini A Pianetti MR Biffi G Brandi L Salvaggio V Albano, Eur J Epidemiol 1995 11 83 86 10.1007/BF01719950 7489778
14. Prevalence of enteric pathogens among community based asymptomatic individuals. ME Hellard MI Sinclair GG Hogg CK Fairley, J Gastroenterol Hepatol 2000 15 290 293 10.1046/j.1440-1746.2000.02089.x 10764030
15. Antibodies, directed towards Campylobacter jejuni antigens, in sera from poultry abattoir workers. SA Cawthraw L Lind B Kaijser DG Newell, Clin Exp Immunol 2000 122 55 60 10.1046/j.1365-2249.2000.01349.x 11012618
16. Campylobacter immunity and coinfection following a large outbreak in a farming community. KJ Forbes FJ Gormley JF Dallas O Labovitiadi M MacRae RJ Owen J Richardson NJ Strachan JM Cowden ID Ogden CC McGuigan, J Clin Microbiol 2009 47 111 116 10.1128/JCM.01731-08 19005146
17. Does age acquired immunity confer selective protection to common serotypes of Campylobacter jejuni? G Miller GM Dunn TM Reid ID Ogden NJ Strachan, BMC Infect Dis 2005 5 66 10.1186/1471-2334-5-66 16117832
18. Has retail chicken played a role in the decline of human campylobacteriosis? FJ Gormley M Macrae KJ Forbes ID Ogden JF Dallas NJ Strachan, Appl Environ Microbiol 2008 74 383 390 10.1128/AEM.01455-07 18065605
19. Multilocus sequence typing system for Campylobacter jejuni. KE Dingle FM Colles DR Wareing R Ure AJ Fox FE Bolton HJ Bootsma RJ Willems R Urwin MC Maiden, J Clin Microbiol 2001 39 14 23 10.1128/JCM.39.1.14-23.2001 11136741
20. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study. KO Gradel M Norgaard C Dethlefsen HC Schonheyder B Kristensen T Ejlertsen H Nielsen, Ann Hematol 2009 88 761 767 10.1007/s00277-008-0662-x 19083236
21. Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study. M Helms P Vastrup P Gerner-Smidt K Molbak, BMJ 2003 326 357 10.1136/bmj.326.7385.357 12586666
22. Hypogammaglobulinemia and recurrent Campylobacter jejuni infection. WD LeBar RR Menard FE Check, J Infect Dis 1985 152 1099 1100 4045252
23. Diabetes mellitus, anti-secretory drugs and other risk factors for Campylobacter gastro-enteritis in adults: a case-control study. KR Neal RC Slack, Epidemiol Infect 1997 119 307 311 10.1017/S0950268897008224 9440433
24. Risk factors for sporadic Campylobacter infection: an all-Ireland case-control study. K Danis M Di Renzi W O'Neill B Smyth P McKeown B Foley V Tohani M Devine, Euro Surveill 2009 14
25. Population-attributable risk estimates for risk factors associated with Campylobacter infection, australia. RJ Stafford PJ Schluter AJ Wilson MD Kirk G Hall L Unicomb, Emerg Infect Dis 2008 14 895 901 10.3201/eid1406.071008 18507899 (Pubitemid 351838597)
26. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study. Y Doorduyn WE Van Den Brandhof YT VAN Duynhoven BJ Breukink JA Wagenaar W VANP, Epidemiol Infect 2010 1 14
27. Omeprazole as a risk factor for Campylobacter gastroenteritis: case-control study. KR Neal HM Scott RC Slack RF Logan, BMJ 1996 312 414 415 8601113
28. Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken. P Effler MC Ieong A Kimura M Nakata R Burr E Cremer L Slutsker, J Infect Dis 2001 183 1152 1155 10.1086/319292 11237847
29. Infections associated with steroid use. NC Klein CH Go BA Cunha, Infect Dis Clin North Am 2001 15 423 432 viii 10.1016/S0891-5520(05)70154-9 11447704
30. Public Health Agency of Canada, C-EnterNet 2006 Annual Report/National Integrated Enteric Pathogen Surveillance Program Public Health Agency of Canada 2007
31. The study of infectious intestinal disease in England: what risk factors for presentation to general practice tell us about potential for selection bias in case-control studies of reported cases of diarrhoea. CC Tam LC Rodrigues SJ O'Brien, Int J Epidemiol 2003 32 99 105 10.1093/ije/dyg007 12690019
32. Risk factors for indigenous Campylobacter infection: a Swedish case-control study. A Studahl Y Andersson, Epidemiol Infect 2000 125 269 275 10.1017/S0950268899004562 11117949
33. Age-specific risk factors for sporadic Campylobacter infection in regional Australia. LE Unicomb CB Dalton GL Gilbert NG Becker MS Patel, Foodborne Pathog Dis 2008 5 79 85 10.1089/fpd.2007.0047 18260818
34. Sporadic Campylobacter infection in infants: a population-based surveillance case-control study. KE Fullerton LA Ingram TF Jones BJ Anderson PV McCarthy S Hurd B Shiferaw D Vugia N Haubert T Hayes,, et al. Pediatr Infect Dis J 2007 26 19 24 10.1097/01.inf.0000247137.43495.34 17195700
35. Rate of Campylobacter spp. isolation in three regions of Ontario, Canada, from 1978 to 1985. JS Thompson FE Cahoon DS Hodge, J Clin Microbiol 1986 24 876 878 3771774
36. Campylobacter excreted into the environment by animal sources: prevalence, concentration shed, and host association. ID Ogden JF Dallas M MacRae O Rotariu KW Reay M Leitch AP Thomson SK Sheppard M Maiden KJ Forbes NJ Strachan, Foodborne Pathog Dis 2009 6 1161 1170 10.1089/fpd.2009.0327 19839759
37. Investigating vomiting and/or bloody diarrhoea in Campylobacter jejuni infection. IA Gillespie SJ O'Brien JA Frost C Tam D Tompkins KR Neal Q Syed MJ Farthing, J Med Microbiol 2006 55 741 746 10.1099/jmm.0.46422-0 16687593
38. Campylobacter jejuni and related species. MJ Blaser BM Allos, Mandell, Douglas, and Bennett's: Principles and Practice of Infectious Diseases Philadelphia, Pennsylvania: Elsevier Inc, Mandell GL, Bennett JE, Dolin R, 6 2005 2548 2555
39. Campylobacteriosis in humans (A historical overview). JP Butzler, The Increasing Incidence of Human Campylobacteriosis Report and Proceedings of a WHO Consultation of Experts Copenhagen, Denmark: Department of Communicable Disease Surveillance and Response 2000 38 41
40. Canadian Integrated Surveillance Report for 1995 on Salmonella, Campylobacter and Pathogenic Escherichia coli. Health Canada (Division of Foodborne and Enteric Diseases), Can Commun Dis Rep 1998 24S5
41. RJ Cook JF Lawless, The Statistical Analysis of Recurrent Events New York: Springer 2007